Research Article
Time to Start Delivering Iron Chelation Therapy in Newly Diagnosed Severe β-Thalassemia
Table 2
Comparison between iron status and hepcidin at SF level >1000 ng/ml with group amount of transfusion (
).
| Variable | Amount of transfusion | | Median (IQR) | Mean difference | 95% CI | value | Lower bound | Upper bound |
| SF level | 1–6 | | 1,214 (1,054–1,491) | 46.1 | 1,142.2 | 1,330.2 | 0.454 | 7–12 | | 1162.0 (1002–1508) | 1,138.6 | 1,241.6 | TS at SF >1000 ng/mL | 1–6 | | 84.8 (36.2–100.0) | 8.1 | 74.2 | 93.9 | 0.084 | 7–12 | | 81.8 (30.1–96.1) | 69.3 | 82.6 | Hepcidin at SF >1000 ng/mL | 1–6 | | 367.9 (176.1–876.0) | 26.3 | 304.2 | 537.5 | 0.765 | 7–12 | | 362.6 (203.1–785.6) | 339.5 | 449.6 | |
|
|
|